Pseudomonas aeruginosa biofilms are intrinsically resistant to antimicrobial chemotherapies.
At present, very little is known about the physiological changes that occur during the …

Lung disease is the leading cause of morbidity and mortality in cystic fibrosis (CF) patients.
A modest number of bacterial pathogens have been correlated with pulmonary function …

We have investigated a potential role for GacA, the response regulator of the GacA/GacS
two‐component regulatory system, in Pseudomonas aeruginosa biofilm formation. When gacA …

A number of human infections are characterized by the presence of more than one bacterial
species and are defined as polymicrobial diseases. Methods for the analysis of the complex …

Objectives Although inadequate antimicrobial therapy has been demonstrated in multiple
studies to increase the risk for death in bacterial infections, few data investigating the effect of …

Chronic lower airway infection with Pseudomonas aeruginosa is a major contributor to
morbidity and mortality in individuals suffering from the genetic disease cystic fibrosis (CF). …

The microbiome of the respiratory tract, including the nasopharyngeal and oropharyngeal
microbiota, is a dynamic community of microorganisms that is highly diverse. The cystic …

The opportunistic pathogen Pseudomonas aeruginosa chronically infects the lower airways
of patients with cystic fibrosis. Throughout the course of infection this organism undergoes …

Chronic suppurative lower airway infection is a hallmark feature of cystic fibrosis (CF).
Decades of experience in clinical microbiology have enabled the development of improved …

Background. A study was conducted in the Calgary Health Region between May 2002 and
April 2004 to define the population‐based epidemiological characteristics of infections …